CCL2 and CCL7, both highly expressed in tumor microenvironment, can recruit various immune cells (such as myeloid-derived suppressor cells, MDSCs) to form an immune-suppressive microenvironment, allowing tumor cell to evade from the body's immune surveillance and supporting tumor cell proliferation. This evidence concerns the gene CCL2 and neoplasm.